Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop ...
T cells use T cell receptors (TCRs) to identify and eliminate diseased cells. T cells equipped with cancer-targeting TCRs can detect and eliminate cancer cells, and TCR-based T cell therapies have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results